Blocking a Brain Signal To Counter Cancer-Associated Cachexia

An RNA-based therapy targeting the GFRAL receptor prevented the wasting process underlying cancer cachexia. Having shown promise in preclinical work, the therapy has potential to improve outcomes in cancer care.